Health Professional Radio - Podcast

Phase 3 Trial Results of Fezolinetant for Treatment of Vasomotor Symptoms

Informações:

Sinopsis

Dr. Samuel Lederman, obstetrician, gynecologist, and a founding member of Palm Beach Obstetrics & Gynecology discusses the positive results from the Phase 3 pivotal SKYLIGHT 1™ and SKYLIGHT 2™ clinical trials for fezolinetant, an investigational oral, nonhormonal compound that was studied for the treatment of moderate to severe vasomotor symptoms (VMS), also known as hot flashes, associated with menopause. Dr. Samuel Lederman, obstetrician and gynecologist, is the founding member of Palm Beach Obstetrics & Gynecology, the most innovative practice in Palm Beach County, with three locations to serve women throughout their entire life cycle.A south Florida native, Dr. Lederman began practicing obstetrics and gynecology in 1991. In 2001, he established Palm Beach Obstetrics & Gynecology. Dr. Lederman began his education in a field unrelated to medicine, obtaining a Bachelor's Degree in Computer Science from Duke University in 1983. He then attended medical school at the University of Miami Miller Sch